Chronic lymphocytic leukemia

Mayo Clinic Health Manager

Get free personalized health guidance for you and your family.

Get Started

Free

E-Newsletter

Subscribe to receive the latest updates on health topics. About our newsletters

  • Housecall
  • Alzheimer's caregiving
  • Living with cancer

Causes

By Mayo Clinic staff

Living with cancer newsletter

Subscribe to our Living with cancer newsletter to stay up to date on cancer topics.

Doctors aren't certain what starts the process that causes chronic lymphocytic leukemia. Doctors know that something happens in order to cause a genetic mutation in the DNA of blood-producing cells. This mutation causes the blood cells to produce abnormal, ineffective lymphocytes — one type of white blood cell that helps your body fight infection.

Beyond being ineffective, these abnormal lymphocytes continue to live, when other cells would die. The abnormal lymphocytes begin accumulating in the blood and certain organs, where they cause complications. They may crowd healthy cells out of the bone marrow and interfere with normal blood cell production.

Doctors and researchers are working to understand the exact mechanism that causes chronic lymphocytic leukemia.

References
  1. Montserrat E, et al. Chronic lymphocytic leukaemia: A short overview. Annals of Oncology. 2008;19(suppl):vii320.
  2. Caligaris-Cappio F, et al. Novel insights in chronic lymphocytic leukemia: Are we getting closer to understanding the pathogenesis of the disease? Journal of Clinical Oncology. 2008;26:4497.
  3. Elphee EE. Caring for patients with chronic lymphocytic leukemia. Clinical Journal of Oncology Nursing. 2008;12:417.
  4. Dighiero G, et al. Chronic lymphocytic leukaemia. The Lancet. 2008;371(9617):1017.
  5. Nabhan C, et al. Controversies in the front-line management of chronic lymphocytic leukemia. Leukemia Research. 2008;32:679.
  6. Chronic lymphocytic leukemia treatment (PDQ) patient version. National Cancer Institute. http://www.cancer.gov/cancertopics/pdq/treatment/CLL/patient/allpage/print. Accessed Oct. 13, 2008.
  7. Hallek M, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: A report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute Working Group 1996 guidelines. Blood. 2008;111:5446.
  8. SEER stat fact sheets. Surveillance Epidemiology and End Results. http://seer.cancer.gov/statfacts/html/clyl.html. Accessed Oct. 15, 2008.
  9. Questions about treatment. The Leukemia & Lymphoma Society. http://www.leukemia-lymphoma.org/graphics/National/Allquestionsworksheets/QuestionsabouttreatmentPS172R.pdf. Accessed Oct. 15, 2008.
  10. Campath (prescribing information). Cambridge, Mass.: Genzyme Corp.; 2007. http://www.fda.gov/cder/foi/label/2007/103948s5070lbl.pdf. Accessed Oct. 15, 2008.
  11. Rituxan (prescribing information). San Francisco, Calif.: Genentech; 2008. http://www.fda.gov/cder/foi/label/2008/103705s5256lbl.pdf. Accessed Oct. 15, 2008.
  12. Cancer-related fatigue. Fort Washington, Pa.: National Comprehensive Cancer Network. http://www.nccn.org/professionals/physician_gls/PDF/fatigue.pdf. Accessed Oct. 15, 2008.
  13. Shanafelt TD (expert opinion). Mayo Clinic, Rochester, Minn. Nov. 12, 2008.

DS00565

Nov. 26, 2008

© 1998-2010 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.com," "EmbodyHealth," "Enhance your life," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.

Print Share Reprints

Text Size: smaller largerlarger